Neurospheres derived from human embryoid bodies treated with retinoic Acid show an increase in nestin and ngn2 expression that correlates with the proportion of tyrosine hydroxylase-positive cells.
In the central nervous system (CNS), generation of phenotypic diversity within the neuronal lineage is precisely regulated in a spatial and temporal fashion. Neural basic helix-loop-helix (bHLH) transcription factors are cell intrinsic factors that control commitment to neuronal lineage and play an important role in neuronal cell type specification. The ability to differentiate human embryonic stem (hES) cells into neurons provides a good model system to address human neuronal specification. Previous studies have shown neurogenin-2 (Ngn2) to be involved in the development of mesencephalic dopaminergic neurons. Toward the goal of correlating neuronal phenotype with early gene expression pattern, we have characterized the expression of Ngn2 during hES cell differentiation. Our results show that treatment of embryoid bodies (EBs) with retinoic acid (RA) leads to the greatest proportion of tyrosine hydroxylase (TH)-positive cells followed by vasoactive intestinal peptide (VIP)-treated EBs as compared to untreated EBs. This increase in the proportion of TH-positive neurons was correlated with the unique morphology of RA-treated aggregates and the spatial delocalization of the expression of Ngn2 within the EB. Neurospheres derived from RA-treated EBs contained many nestin-positive cells within regions that expressed Ngn2. We show that the extent of nestin-positive cells that arise from the region of Ngn2 expression is correlated with the appearance of TH-positive neurons. Our results show for the first time the expression of Ngn2 during the differentiation of hES cells.
Kumar
Manoj
M
National Brain Research Centre, Manesar, Gurgaon 122050, India.
Bagchi
Bandita
B
Gupta
Shailesh Kumar
SK
Meena
A S
AS
Gressens
Pierre
P
Mani
Shyamala
S
D051792:Basic Helix-Loop-Helix Proteins / Q000235:genetics*; D018929:Cell Culture Techniques; D002454:Cell Differentiation / Q000187:drug effects; D017931:DNA Primers; D053595:Embryonic Stem Cells / Q000166:cytology / Q000187:drug effects / Q000201:enzymology / Q000502:physiology*; D006801:Humans; D007381:Intermediate Filament Proteins / Q000235:genetics*; D009419:Nerve Tissue Proteins / Q000235:genetics*; D064231:Nestin; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000201:enzymology / Q000502:physiology*; D016133:Polymerase Chain Reaction; D014212:Tretinoin / Q000494:pharmacology*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*